Insulin human
- Generic Name
- Insulin human
- Brand Names
- Actraphane, Actrapid, Afrezza, Entuzity, Exubera, Humulin, Humulin N, Humulin R, Insulatard, Insuman, Myxredlin, Novolin, Novolin N, Novolin R, Protaphane, Mixtard
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 11061-68-0
- Unique Ingredient Identifier
- 1Y17CTI5SR
- Background
Human Insulin, also known as Regular Insulin, is a short-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Human insulin is produced by recombinant DNA technology and is identical to endogenously produced insulin. Typically prescribed for the management of diabetes mellitus, insulin is a peptide hormone prod...
- Indication
Human insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.
- Associated Conditions
- Diabetes Mellitus, Type 1 Diabetes Mellitus
- Associated Therapies
- -
Insulin for Hyperglycemia in Stroke Trial
- Conditions
- Interventions
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-12-06
- Target Recruit Count
- 452
- Registration Number
- NCT04834362
- Locations
- 🇧🇩
National Institute of Neurosciences and Hospital, Dhaka, Bangladesh
Brain Insulin Resistance in Mood Disorders
- Conditions
- Interventions
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 150
- Registration Number
- NCT03915613
- Locations
- 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada
Neuro Biomarkers of Smoking Behavior
- First Posted Date
- 2019-01-22
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 4
- Registration Number
- NCT03811951
- Locations
- 🇺🇸
University of Illinois Department of Pharmacy Practice, Chicago, Illinois, United States
Pupillography as Screening Tool for Brain Insulin Resistance
- Conditions
- Interventions
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 22
- Registration Number
- NCT03651661
- Locations
- 🇩🇪
University of Tuebingen, Department of Internal Medicine IV, Tübingen, Germany
HbA1c Variability in Type II Diabetes
- Conditions
- Interventions
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Weill Cornell Medical College in Qatar
- Target Recruit Count
- 150
- Registration Number
- NCT02879409
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
- Conditions
- Interventions
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Hiroaki Sato, MD., PhD.
- Target Recruit Count
- 141
- Registration Number
- NCT02729064
- Locations
- 🇨🇦
Royal Victoria Hospital McGill University Health Centre, Montreal, Quebec, Canada
Primary Intervention With Mucosal Insulin
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 25
- Registration Number
- NCT02620553
- Locations
- 🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 21
- Registration Number
- NCT02468999
- Locations
- 🇩🇪
University of Tuebingen, Department of Internal Medicine IV, Tübingen, Germany
Changing Diabetes in Children
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2015-03-09
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 3089
- Registration Number
- NCT02382757
Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay
- Conditions
- Interventions
- First Posted Date
- 2014-10-30
- Last Posted Date
- 2014-10-30
- Lead Sponsor
- Universidad Nacional de Asunción
- Target Recruit Count
- 134
- Registration Number
- NCT02278913
- Locations
- 🇵🇾
ClÃnica Médica del Hospital de ClÃnicas, Universidad Nacional de Asunción,, Asuncion, Paraguay
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.